COPD is a long-term lung disease that makes it hard to breathe and often causes coughing, wheezing, and frequent lung infections.
Chronic Obstructive Pulmonary Disease (COPD)
COPD is a progressive lung disease that encompasses different conditions, such as emphysema and chronic bronchitis. COPD is characterized by limited airflow and breathing difficulties, and while it is uncurable, its progression and symptoms can be managed through different treatments.
Upcoming Clinical Trial for Moderate to Very Severe COPD
Hightower Clinical will soon begin a research study for adults living with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD). This study will test a new investigational treatment to see if it can help reduce flare-ups and improve symptoms in people already on inhaled maintenance medications.
Participants may receive one of two doses of the study drug or a placebo through monthly injections. The study will last up to 76 weeks, with an additional follow-up period to monitor safety. All study-related care will be provided at no cost.
Condition
COPD
Current Status
Upcoming
Location
Oklahoma
Frequently Asked Questions
What is the purpose of this study?
This study is testing whether the study drug can reduce COPD flare-ups and improve breathing in people with moderate to very severe symptoms.
Do I need to stop my current medication?
No. Participants will continue their usual inhaled treatments while receiving the study drug or placebo.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.